ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: ABL1 can normally self-regulate its activity via its engagement with the myristoylated N-terminal; however, in patients with CML, this ability is lost when ABL1 is fused with BCR (Figure 2B) [12].